These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 8072679

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
    Boćkowski L, Okurowska-Zawada B, Sobaniec W, Kułak W, Sendrowski K.
    Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman.
    Koul R, Al-Futaisi A, Ganesh A, Rangnath Bushnarmuth S.
    J Child Neurol; 2007 May; 22(5):555-9. PubMed ID: 17690061
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Recovery function of somatosensory evoked potentials in juvenile myoclonic epilepsy.
    Kızıltan ME, Yeni SN, Aliş C, Gündüz A.
    Somatosens Mot Res; 2019 Sep; 36(3):195-201. PubMed ID: 31366264
    [Abstract] [Full Text] [Related]

  • 30. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.
    Worgall S, Kekatpure MV, Heier L, Ballon D, Dyke JP, Shungu D, Mao X, Kosofsky B, Kaplitt MG, Souweidane MM, Sondhi D, Hackett NR, Hollmann C, Crystal RG.
    Neurology; 2007 Aug 07; 69(6):521-35. PubMed ID: 17679671
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A pathophysiological study of neuronal ceroid lipofuscinoses in 17 patients: critical review and methodological proposal.
    Scaioli V, Nardocci N.
    Neurol Sci; 2000 Aug 07; 21(3 Suppl):S89-92. PubMed ID: 11073234
    [Abstract] [Full Text] [Related]

  • 33. Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy.
    Shibasaki H, Yamashita Y, Neshige R, Tobimatsu S, Fukui R.
    Brain; 1985 Mar 07; 108 ( Pt 1)():225-40. PubMed ID: 3919884
    [Abstract] [Full Text] [Related]

  • 34. Neuronal ceroid lipofuscinoses in childhood.
    Santavuori P, Lauronen L, Kirveskari E, Aberg L, Sainio K, Autti T.
    Neurol Sci; 2000 Mar 07; 21(3 Suppl):S35-41. PubMed ID: 11073226
    [Abstract] [Full Text] [Related]

  • 35. EEG and evoked potentials in infantile neuronal ceroid-lipofuscinosis.
    Vanhanen SL, Sainio K, Lappi M, Santavuori P.
    Dev Med Child Neurol; 1997 Jul 07; 39(7):456-63. PubMed ID: 9285436
    [Abstract] [Full Text] [Related]

  • 36. A Biomarker for Benign Adult Familial Myoclonus Epilepsy: High-Frequency Activities in Giant Somatosensory Evoked Potentials.
    Tojima M, Hitomi T, Matsuhashi M, Neshige S, Usami K, Oi K, Kobayashi K, Takeyama H, Shimotake A, Takahashi R, Ikeda A.
    Mov Disord; 2021 Oct 07; 36(10):2335-2345. PubMed ID: 34050549
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of sodium valproate on somatosensory evoked potentials in juvenile myoclonic epilepsy.
    Erdem H, Yiğit A, Culcuoğlu A, Mutluer N.
    Ups J Med Sci; 2001 Oct 07; 106(3):197-203. PubMed ID: 12166512
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.